SocialPicks: The Stock Idea Community

The FinancialContent Network SocialPicks Community | MarketMinute Monitor | MarketMinute Market Updates | MarketMinute Stock News

Sign Up | Log In | What is SocialPicks?

Good Investment Ideas By People You Trust

SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.

Are you a stock guru?

Share picks & earn reputation

Biotechnology & Drugs picks

Sector: Healthcare

All Sectors

Technology
Services
Financial
Healthcare
Energy Basic Materials
Consumer Cyclical
Capital Goods
Consumer/Non-Cyclical Transportation
Conglomerates
Utilities

November 25

N/A

PARD PARD - Azimuth Opportunity Bets on Poniard's Survival. Should you ?

Sector: Healthcare > Biotechnology & Drugs

I was poring over Poniard Pharmaceuticals' past press releases and financial reports this weekend, wondering how close this Biotech really was to shutting its doors forever. Things certainly did not look rosy. Last Monday, November 16 the company had announced that the pivotal Phase 3 trial o...

Ivan Mutaftchiev

(+0.00%)

Comment

November 24

73%

PBIO Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Unilife

Sector: Healthcare > Biotechnology & Drugs

Below are three under the radar stocks from the healthcare sector that I have been following for the past 3-6 months which have upcoming catalysts in the form of expected strategic deals, clinical trial results, and other corporate developments. Click here to check out my <font> kaChing....

Mike Havrilla

(+1.04% risk: conservative)

Comment

November 23

73%

SCLN BioMed News Bytes: Transcept, SciClone, ProUroCare, ABIO

Sector: Healthcare > Biotechnology & Drugs

On 11/23/09, Transcept Pharma (NASDAQ: TSPT) announced that it is scheduled to meet with the FDA on 1/20/10 to discuss the Complete Response Letter (CRL) regarding the New Drug Application (NDA) for Intermezzo (zolpidem tartrate sublingual tablet). As previously announced, the CRL, received by TSPT ...

Mike Havrilla

(+1.04% risk: conservative)

Comment

42%

SNY Cramer on BloggingStocks: Sanofi has lots of upside catalysts

Sector: Healthcare > Biotechnology & Drugs

Filed under: Analyst reports, Pfizer (PFE), Market matters, Bristol-Myers Squibb (BMY), Merck and Co (MRK), Lilly (Eli) (LLY), Deere and Co (DE), Stocks to Buy, Potash Corp. of Saskatchewan (POT) From TheStreet.com Network Dollar Store: Early Volume Plays Dollar Could Steer Stocks in Coming Week TheStreet.com's Jim Cramer says it looks like the patent worries aren't so dire after al...

Jim Cramer

(+2.37% risk: moderate)

Comment

November 22

73%

NVO Diabetes Care: Global Investing Opportunities

Sector: Healthcare > Biotechnology & Drugs

The <font> American Diabetes Association estimates </font> that there are currently 23.6 million diabetics in the U.S. (7.8% of the total population, including 17.9 million diagnosed cases, 5.7 million undiagnosed, and 57 million pre-diabetics. Diabetes results in an estimated $174 billi...

Mike Havrilla

(+1.04% risk: conservative)

Comment

November 20

73%

DNDN BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen

Sector: Healthcare > Biotechnology & Drugs

On 11/2/09, Dendreon (NASDAQ: DNDN) announced that it has completed the submission of its amended Biologics License Application (BLA) for PROVENGE (sipuleucel-T), seeking approval for men with metastatic castrate-resistant prostate cancer (CRPC). The amended BLA includes data from the IMPACT trial, ...

Mike Havrilla

(+1.04% risk: conservative)

Comment

November 19

80%

ONCY Oncolytics Biotech Inc. down to 2,00 $

Sector: Healthcare > Biotechnology & Drugs

http://cxa.marketwatch.com/TSX/en/Market/article.aspx?guid=ht... CALGARY, Nov 18, 2009 /PRNewswire-FirstCall via COMTEX/ -- Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (ONC)(US:ONCY) announced today that it has entered into an underwriting agreement for an offering of 4,250,000 units, ...

Yannis Maarten

(+1.70% risk: conservative)

Comment

Get Daily Alerts in Biotechnology & Drugs

Get free alerts and recommendations from proven top-performing SocialPicks members

Top Rated Stocks in Sector

Symbol	Company Name	Sentiment
EXAS	EXACT Sciences Corp.
LJPC	La Jolla Pharmaceutical Company
AGEN	Antigenics Inc.
EW	Edwards Lifesciences Corp.
SLXP	Salix Pharmaceuticals Ltd.
AMAG	Advanced Magnetics Inc.
NBIX	Neurocrine Biosciences Inc.
BAX	Baxter International Inc.

View All Stock Ratings »

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.